App is temporarily unavailable
Description
N/A
In-Apps
- 购买在线问诊
- €8.99
Screenshots
N/A FAQ
-
Is 芬芳医生 free?
Yes, 芬芳医生 is free to download, however it contains in-app purchases or subscription offerings.
-
Is 芬芳医生 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 芬芳医生 cost?
芬芳医生 has several in-app purchases/subscriptions, the average in-app price is €8.99.
-
What is 芬芳医生 revenue?
To get estimated revenue of 芬芳医生 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Italy yet.
Ratings History
N/A Reviews
N/A Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
金草医生
数字化诊疗更高效
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
快问医生版
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
国浩中医
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Fragrance Blends
Essential oils blend recipes
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
GlycoLeap - Your Health Coach
A smart coach for weight loss
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
网医联盟-移动互联网诊疗平台
在家随时随地看专家
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
Self Cure remedies for ailment
Self cure guide for illness
|
Unlock
|
Unlock
|
0
|
|
6 years ago | |
南风医生
专注慢病 服务到家 健康管理 运动步数
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
疗方笺
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
掌上药店 - 一站式海内外药品信息服务平台
为用户提供一站式海内外药品信息及检测服务
|
Unlock
|
Unlock
|
0
|
|
11 months ago |
芬芳医生 Installs
Last 30 days
芬芳医生 Revenue
Last 30 daysN/A Revenue and Downloads
Gain valuable insights into 芬芳医生 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Guangxi Liheng E-Commerce Co
- Languages
- Chinese, English
- Recent release
- 1.0 (3 years ago )
- Released on
- Aug 18, 2021 (3 years ago )
- Also available in
- Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Switzerland , Chile , China , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.